Yeh PY - Search Results

1

Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.

Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Wu TC, Gao M, Cheng AL. Hsu CH, et al. Among authors: yeh py. Anticancer Res. 2002 Nov-Dec;22(6C):4065-71. Anticancer Res. 2002. PMID: 12553034

2

The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma.

Lin ZZ, Hsu HC, Hsu CH, Yeh PY, Huang CY, Huang YF, Chen TJ, Kuo SH, Hsu C, Hu FC, Jeng YM, Chung Y, Cheng AL. Lin ZZ, et al. Among authors: yeh py. J Hepatol. 2009 Mar;50(3):518-27. doi: 10.1016/j.jhep.2008.10.022. Epub 2008 Dec 25. J Hepatol. 2009. PMID: 19155085

3

Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway.

Chen KF, Yeh PY, Hsu C, Hsu CH, Lu YS, Hsieh HP, Chen PJ, Cheng AL. Chen KF, et al. Among authors: yeh py. J Biol Chem. 2009 Apr 24;284(17):11121-33. doi: 10.1074/jbc.M806268200. Epub 2009 Mar 4. J Biol Chem. 2009. PMID: 19261616 Free PMC article.

4

IκB kinases increase Myc protein stability and enhance progression of breast cancer cells.

Yeh PY, Lu YS, Ou DL, Cheng AL. Yeh PY, et al. Mol Cancer. 2011 May 16;10:53. doi: 10.1186/1476-4598-10-53. Mol Cancer. 2011. PMID: 21575199 Free PMC article.

5

Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma.

Chiang CT, Yeh PY, Gao M, Chen CW, Yeh LC, Feng WC, Kuo SH, Hsu CH, Lu YS, Cheng AL. Chiang CT, et al. Among authors: yeh lc, yeh py. Cancer Lett. 2010 Dec 8;298(2):195-203. doi: 10.1016/j.canlet.2010.07.005. Epub 2010 Jul 31. Cancer Lett. 2010. PMID: 20673698

6

Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.

Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY, Cheng AL. Chen KF, et al. Among authors: yeh py, yeh kh. Cancer Res. 2008 Aug 15;68(16):6698-707. doi: 10.1158/0008-5472.CAN-08-0257. Cancer Res. 2008. PMID: 18701494

7

Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity.

Lu YS, Lien HC, Yeh PY, Kuo SH, Chang WC, Kuo ML, Cheng AL. Lu YS, et al. Among authors: yeh py. Lung Cancer. 2006 Sep;53(3):303-10. doi: 10.1016/j.lungcan.2006.05.005. Epub 2006 Jun 27. Lung Cancer. 2006. PMID: 16806572

8

Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa.

Lu YS, Yeh PY, Chuang SE, Gao M, Kuo ML, Cheng AL. Lu YS, et al. Among authors: yeh py. J Endocrinol. 2006 Feb;188(2):311-9. doi: 10.1677/joe.1.06453. J Endocrinol. 2006. PMID: 16461557

9

Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.

Lu YS, Lien HC, Yeh PY, Yeh KH, Kuo ML, Kuo SH, Cheng AL. Lu YS, et al. Among authors: yeh py, yeh kh. World J Gastroenterol. 2005 Oct 28;11(40):6373-80. doi: 10.3748/wjg.v11.i40.6373. World J Gastroenterol. 2005. PMID: 16419168 Free PMC article.

10

Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro.

Hsu CH, Gao M, Chen CL, Yeh PY, Cheng AL. Hsu CH, et al. Among authors: yeh py. Oncology. 2005;68(4-6):538-47. doi: 10.1159/000086998. Epub 2005 Jul 20. Oncology. 2005. PMID: 16037687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results